Results 1 to 10 of about 208,152 (156)

Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union [PDF]

open access: yesSaudi Pharmaceutical Journal, 2023
Background: Rare diseases are chronic, serious, and life-threatening conditions that have not received sufficient attention from drug developers due to their rarity.
Bander Balkhi   +2 more
doaj   +4 more sources

Drug policies’ sensitivity towards women, pregnancy, and motherhood: a content analysis of national policy and programs from nine countries and their adherence to international guidelines [PDF]

open access: yesAddiction Science & Clinical Practice, 2023
Background and objectives Substance use in women is associated with unique psycho-social and physical vulnerabilities and poses complex challenges during pregnancy and motherhood.
Abhishek Ghosh   +10 more
doaj   +2 more sources

Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies [PDF]

open access: yesFrontiers in Pharmacology, 2018
Drug scheduling within the international system of drug control and national legislation has been recently criticized as having insufficient footing in scientific evidence.
Veljko Dubljević, Veljko Dubljević
doaj   +2 more sources

Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties [PDF]

open access: yesHarm Reduction Journal
Background In many rural US Appalachian and Midwestern counties, stigma surrounding harm reduction interventions has led health professionals and policymakers to approach drug policy implementation with caution, fearing potential backlash from ...
Xi Liu   +3 more
doaj   +2 more sources

Reframing Dutch drug policies: a new era for harm reduction [PDF]

open access: yesHarm Reduction Journal
In this article the authors offer their perspective on the changes in the Dutch harm reduction field. From the 1970s to the 1990s, the Netherlands emerged as a leader in harm reduction services, driven by grassroots movements like the Medisch-sociale ...
Machteld Busz   +3 more
doaj   +2 more sources

National drug policies

open access: yesLancet, The, 1995
R O, Laing, D G, Ross-Degnan
exaly   +3 more sources

Drug Use and Drug Policy [PDF]

open access: yesJournal of Institutional and Theoretical Economics, 2002
Early in the twentieth century the Dutch East Indies (present-day Indonesia) had a government monopoly on the import, refining, and retailing of opium. There were regional differences in opium policy ranging from areas with prohibition to areas where opium use was hardly restricted.
Luijk, Eric W. van, Ours, Jan C. van
openaire   +3 more sources

Decolonizing drug policy [PDF]

open access: yesHarm Reduction Journal, 2021
AbstractThis paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries. It demonstrates the racist and xenophobic impact of drug control policy and proposes a path to move beyond oppressive systems and structures.
Colleen Daniels   +8 more
openaire   +4 more sources

Introduction Special Issue: Environmental Impacts of Illicit Economies

open access: yesJournal of Illicit Economies and Development, 2021
For decades, illicit economies have predominantly been studied and debated as a security problem with social and development consequences. However, the interaction between illicit economies and the environment, in cases such as illicit drug crop ...
Daniel Brombacher   +2 more
doaj   +1 more source

Drug Policy in Greece [PDF]

open access: yesValue in Health Regional Issues, 2018
To provide a detailed overview of the recent reforms in pharmaceutical pricing and reimbursement processes as well as in other important areas of the pharmaceutical policy in Greece.Information was collected via a structured questionnaire. The study used publicly available resources, such as publications, relevant legislation, and statistical data ...
Yfantopoulos, J.N., Chantzaras, A.
openaire   +3 more sources

Home - About - Disclaimer - Privacy